GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (TSE:4593) » Definitions » Net Income Including Noncontrolling Interests

Healios KK (TSE:4593) Net Income Including Noncontrolling Interests : 円-5,387.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Healios KK Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Healios KK's Net Income Including Noncontrolling Interests for the three months ended in Jun. 2024 was 円-530.0 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2024 was 円-5,387.0 Mil.

Healios KK Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Healios KK's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healios KK Net Income Including Noncontrolling Interests Chart

Healios KK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,805.00 -5,511.00 -4,911.00 -5,170.00 -3,813.00

Healios KK Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -655.00 -692.00 -1,737.00 -2,428.00 -530.00

Healios KK Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-5,387.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healios KK Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Healios KK's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Healios KK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (TSE:4593) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
TSE:4894 TSE:4572 TSE:4571 TSE:2183 TSE:3750 TSE:2370 TSE:4891 TSE:7776 TSE:4579 TSE:4598 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
HLOSF:USA
Address
World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115
Website
https://www.healios.co.jp
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.

Healios KK Headlines

No Headlines